Overview

Drug-drug Interaction of Empagliflozin (BI 10773) and Simvastatin

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the study is to investigate the drug-drug interaction potential between BI 10773 and simvastatin.
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Empagliflozin
Simvastatin